Euroopa Liit - eesti - EMA (European Medicines Agency)

accord healthcare s.l.u. - lakosamiid - epilepsia - antiepileptics, - lacosamide accord is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. lacosamide accord is indicated as adjunctive therapy•         in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. •         in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.

Euroopa Liit - eesti - EMA (European Medicines Agency)

ucb pharma s.a. - lakosamiid - epilepsiad, osaline - antiepileptics, - lacosamide ucb on näidustatud monotherapy ja adjunctive ravi ravi osaline algusega krambid koos või ilma sekundaarse teha üldistusi täiskasvanud, noorukid ja lapsed alates 4-aastastel epilepsia.

Euroopa Liit - eesti - EMA (European Medicines Agency)

extrovis eu ltd. - lakosamiid - epilepsia - antiepileptics, - lacosamide adroiq is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. lacosamide adroiq is indicated as adjunctive therapyin the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.

Eesti - eesti - Ravimiamet

alembic pharmaceuticals europe limited - lakosamiid - õhukese polümeerikattega tablett - 100mg 14tk; 100mg 168tk; 100mg 56tk; 100mg 28tk

Eesti - eesti - Ravimiamet

alembic pharmaceuticals europe limited - lakosamiid - õhukese polümeerikattega tablett - 200mg 56tk; 200mg 28tk; 200mg 168tk; 200mg 14tk

Eesti - eesti - Ravimiamet

alembic pharmaceuticals europe limited - lakosamiid - õhukese polümeerikattega tablett - 50mg 168tk; 50mg 56tk; 50mg 28tk; 50mg 14tk

Eesti - eesti - Ravimiamet

alembic pharmaceuticals europe limited - lakosamiid - õhukese polümeerikattega tablett - 150mg 28tk; 150mg 168tk; 150mg 14tk

Eesti - eesti - Ravimiamet

fresenius kabi polska sp. z o.o. - lakosamiid - infusioonilahus - 10mg 1ml 20ml 5tk; 10mg 1ml 20ml 10tk; 10mg 1ml 20ml 1tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

ucb pharma sa - lakosamiid - epilepsia - antiepileptics, - vimpat on näidustatud monoteraapia ja täiendav ravi partsiaalsete krampide puhul koos sekundaarse generaliseerumisega või ilma täiskasvanutele, noorukitel ja lastel alates vanusest 4 aastat.

Eesti - eesti - Ravimiamet

medochemie limited - lakosamiid - õhukese polümeerikattega tablett - 100mg 14tk; 100mg 56tk; 100mg 7tk; 100mg 168tk